N/A
N=385
Advance Planning for Home Services for Seniors
Alzheimers, Falls, Aging in Place
Bottom Line
View on ClinicalTrials.gov: NCT02256072 ↗Enrolled (actual)
385
Serious AEs
0.0%
Results posted
Feb 2017
Primary outcome: Primary: Planning Behavior Score at 1-month — 16.97; 16.80; 17.19; 15.88 units on a scale — p=0.0054
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Plan Your Lifespan Website (Other); Go4Life Website (Other)
- Age
- Older Adult · 65+ yrs
- Sex
- All
- Sponsor
- Northwestern University
- Primary completion
- Dec 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Planning Behavior Score at 1-month |
16.97; 16.80; 17.19; 15.88 | 0.0054 sig |
| SECONDARY Planning Perception Score at Baseline, Immediate Post-test, 1 and 3-months |
19.75; 20.11; 20.70; 20.01; 20.75; 20.29 | 0.0471 sig |
| SECONDARY Confidence in Accessing Home Services Score at Immediate Post-test, 1 and 3-months |
20.85; 20.70; 21.39; 20.67; 21.74; 21.19 | 0.423 |
| SECONDARY Knowledge of Home Services Score at Immediate Post-test, 1 and 3-months |
3.56; 3.79; 4.12; 3.93; 4.10; 3.72 | <0.0001 sig |
| SECONDARY Satisfaction With Intervention Tool Score at Immediate Post-test, 1 and 3-months |
— | — |
Summary
The goal of this study is to develop and test an advance planning tool to help seniors understand projected health needs and plan ways to remain in their own homes when these crises occur. In this phase of the study through partnerships with seniors, senior community groups, area agencies on aging, and home care agencies the investigators are conducting a two-armed (attention control and intervention) randomized controlled trial.
Individuals will be randomly assigned to one of two interventions: attention control or the advance planning tool. The investigators attention control group will control for the possibility that regular contact with the study team may improve outcomes in participants randomized to the intervention website. Participants in the attention control arm will navigate an electronic educational session via a National Institute on Aging at NIH Web site about physical activity and exercise as it is a topic of interest to seniors. A minimum of 15 minutes and a maximum of 45 minutes will be allotted for navigating the Web site. The Web site is interactive and comparable to the intervention tool: http://go4life.nia.nih.gov/get-started).
If randomized to intervention, subjects will be introduced to the advance planning tool, the Plan Your Lifespan website, and given instructions on how to use it. Plan Your Lifespan is a Web-based planning tool that provides information for seniors related to advanced health planning for home services in specific content areas of: hospitalizations, falls, Alzheimer's, dementia, as well as communicating with others. The Plan Your Lifespan website is also interactive in that it allows participants to enter their information and share it with others to facilitate conversations and decision-making. Participants will navigate and complete the Web-based advance planning tool and will be allotted a minimum of 15 minutes and a maximum of 45 minutes to navigate the tool as part of the study.
All participants will be administered a pre- and post-test before and after viewing the website they were randomized to. All participants will be followed up at one and three months post via a brief phone call where follow-up questions will be asked of all participants.
Eligibility Criteria
Inclusion Criteria
- Age 65 and older
- English speaking
- Score ≥ 4 questions correctly on the Brief Cognitive screener
- Self-identified comfort using a computer
- Self-identified comfort using the Internet to navigate a Website
- Have not previously participated in study's focus groups or pilot study
Exclusion Criteria
- Less than age 65
- Non-English speaking
- Score < 4 questions correctly on the Brief Cognitive screener
- Not comfortable using a computer
- Not comfortable using the Internet to navigate a Website
- Previous participation in this study's focus groups or pilot study
Data sourced from ClinicalTrials.gov (NCT02256072). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.